Literature DB >> 23237318

A population-specific uncommon variant in GRIN3A associated with schizophrenia.

Atsushi Takata1, Yoshimi Iwayama, Yasuhisa Fukuo, Masashi Ikeda, Tomo Okochi, Motoko Maekawa, Tomoko Toyota, Kazuo Yamada, Eiji Hattori, Tetsuo Ohnishi, Manabu Toyoshima, Hiroshi Ujike, Toshiya Inada, Hiroshi Kunugi, Norio Ozaki, Shinichiro Nanko, Kazuhiko Nakamura, Norio Mori, Shigenobu Kanba, Nakao Iwata, Tadafumi Kato, Takeo Yoshikawa.   

Abstract

BACKGROUND: Genome-wide association studies have successfully identified several common variants showing robust association with schizophrenia. However, individually, these variants only produce a weak effect. To identify genetic variants with larger effect sizes, increasing attention is now being paid to uncommon and rare variants.
METHODS: From the 1000 Genomes Project data, we selected 47 candidate single nucleotide variants (SNVs), which were: 1) uncommon (minor allele frequency < 5%); 2) Asian-specific; 3) missense, nonsense, or splice site variants predicted to be damaging; and 4) located in candidate genes for schizophrenia and bipolar disorder. We examined their association with schizophrenia, using a Japanese case-control cohort (2012 cases and 2781 control subjects). Additional meta-analysis was performed using genotyping data from independent Han-Chinese case-control (333 cases and 369 control subjects) and family samples (9 trios and 284 quads).
RESULTS: We identified disease association of a missense variant in GRIN3A (p.R480G, rs149729514, p = .00042, odds ratio [OR] = 1.58), encoding a subunit of the N-methyl-D-aspartate type glutamate receptor, with study-wide significance (threshold p = .0012). This association was supported by meta-analysis (combined p = 3.3 × 10(-5), OR = 1.61). Nominally significant association was observed in missense variants from FAAH, DNMT1, MYO18B, and CFB, with ORs of risk alleles ranging from 1.41 to 2.35.
CONCLUSIONS: The identified SNVs, particularly the GRIN3A R480G variant, are good candidates for further replication studies and functional evaluation. The results of this study indicate that association analyses focusing on uncommon and rare SNVs are a promising way to discover risk variants with larger effects.
Copyright © 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23237318     DOI: 10.1016/j.biopsych.2012.10.024

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  20 in total

Review 1.  Emerging roles of GluN3-containing NMDA receptors in the CNS.

Authors:  Isabel Pérez-Otaño; Rylan S Larsen; John F Wesseling
Journal:  Nat Rev Neurosci       Date:  2016-08-25       Impact factor: 34.870

Review 2.  Implication of Genes for the N-Methyl-D-Aspartate (NMDA) Receptor in Substance Addictions.

Authors:  Jiali Chen; Yunlong Ma; Rongli Fan; Zhongli Yang; Ming D Li
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

3.  The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Paul J Gresch; Stephanie C Gantz; John Williams; Gwynne L Davis; C Austin Wheeler; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

4.  Identification of a Subtype-Selective Allosteric Inhibitor of GluN1/GluN3 NMDA Receptors.

Authors:  Yue Zeng; Yueming Zheng; Tongtong Zhang; Fei Ye; Li Zhan; Zengwei Kou; Shujia Zhu; Zhaobing Gao
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

5.  Sequencing and expression analyses of the synaptic lipid raft adapter gene PAG1 in schizophrenia.

Authors:  Shabeesh Balan; Yoshimi Iwayama; Kazuo Yamada; Tomoko Toyota; Tetsuo Ohnishi; Manabu Toyoshima; Chie Shimamoto; Masayuki Ide; Yasuhide Iwata; Katsuaki Suzuki; Mitsuru Kikuchi; Tasuku Hashimoto; Nobuhisa Kanahara; Takeo Yoshikawa; Motoko Maekawa
Journal:  J Neural Transm (Vienna)       Date:  2014-07-09       Impact factor: 3.575

Review 6.  Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.

Authors:  Rafael T de Sousa; Alexandre A Loch; André F Carvalho; André R Brunoni; Marie Reine Haddad; Ioline D Henter; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Neuropsychopharmacology       Date:  2016-08-11       Impact factor: 7.853

7.  A polygenic burden of rare disruptive mutations in schizophrenia.

Authors:  Shaun M Purcell; Jennifer L Moran; Menachem Fromer; Douglas Ruderfer; Nadia Solovieff; Panos Roussos; Colm O'Dushlaine; Kimberly Chambert; Sarah E Bergen; Anna Kähler; Laramie Duncan; Eli Stahl; Giulio Genovese; Esperanza Fernández; Mark O Collins; Noboru H Komiyama; Jyoti S Choudhary; Patrik K E Magnusson; Eric Banks; Khalid Shakir; Kiran Garimella; Tim Fennell; Mark DePristo; Seth G N Grant; Stephen J Haggarty; Stacey Gabriel; Edward M Scolnick; Eric S Lander; Christina M Hultman; Patrick F Sullivan; Steven A McCarroll; Pamela Sklar
Journal:  Nature       Date:  2014-01-22       Impact factor: 49.962

8.  Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms.

Authors:  Sandra Sirrs; Clara D M van Karnebeek; Xiaoxue Peng; Casper Shyr; Maja Tarailo-Graovac; Rupasri Mandal; Daniel Testa; Devin Dubin; Gregory Carbonetti; Steven E Glynn; Bryan Sayson; Wendy P Robinson; Beomsoo Han; David Wishart; Colin J Ross; Wyeth W Wasserman; Trevor A Hurwitz; Graham Sinclair; Martin Kaczocha
Journal:  Orphanet J Rare Dis       Date:  2015-03-28       Impact factor: 4.123

9.  Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes.

Authors:  Kazutaka Ohi; Ryota Hashimoto; Masashi Ikeda; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Satomi Umeda-Yano; Masaki Fukunaga; Haruo Fujino; Yoshiyuki Watanabe; Masao Iwase; Hiroaki Kazui; Nakao Iwata; Daniel R Weinberger; Masatoshi Takeda
Journal:  Schizophr Bull       Date:  2014-12-22       Impact factor: 9.306

10.  Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A.

Authors:  Weiwei Zhong; Anika Wu; Ken Berglund; Xiaohuan Gu; Michael Qize Jiang; Jay Talati; Jingjie Zhao; Ling Wei; Shan Ping Yu
Journal:  Alzheimers Dement       Date:  2021-06-20       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.